Using the common cold virus as a naturally occurring vaccine to prevent COVID-19 : lessons from Edward Jenner

Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2020, 'Using the common cold virus as a naturally occurring vaccine to prevent COVID-19 : lessons from Edward Jenner' , Aging, 12 (19) , pp. 18797-18803.

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Three recent papers published in Nature, Science and Cell, all present clear evidence that there is cross-reactive T-cell immunity between human coronaviruses (229E, NL63, OC43, and HKU1), linked with the common cold, and SARS-CoV-2, the causative agent of COVID-19. Can we use this information to design and build a new vaccine based on the less pathogenic, common cold coronaviruses, for the prevention of COVID-19? If we look at the history of medicine and vaccine development, from the point of view of Edward Jenner, the answer just might be yes.

Item Type: Article
Additional Information: ** From PubMed via Jisc Publications Router **Journal IDs: eissn 1945-4589 **Article IDs: pubmed: 33049711; pii: 104166 **History: accepted 30-09-2020; submitted 18-09-2020
Schools: Schools > School of Environment and Life Sciences
Journal or Publication Title: Aging
Publisher: Impact Journals
ISSN: 1945-4589
Related URLs:
Funders: Lunella Biotech, Inc.
SWORD Depositor: Publications Router
Depositing User: Publications Router
Date Deposited: 16 Nov 2020 12:00
Last Modified: 16 Nov 2020 14:37
URI: http://usir.salford.ac.uk/id/eprint/58645

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)

Downloads

Downloads per month over past year